Sulfasalazine: A potential psoriasis therapy?
- 31 May 1989
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 20 (5) , 797-800
- https://doi.org/10.1016/s0190-9622(89)70092-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Determination of 5,12, and 15-Lipoxygenase Products in Keratomed Biopsies of Normal and Psoriatic SkinJournal of Investigative Dermatology, 1988
- Enhanced capacity for release of leucotriene B4 by neutrophils in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1987
- Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acidDigestive Diseases and Sciences, 1987
- The Release of Leukotriene B4-like Material in Biologically Active Amounts from the Lesional Skin of patients with PsoriasisJournal of Investigative Dermatology, 1984
- Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.Journal of Clinical Investigation, 1982
- Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.Journal of Clinical Investigation, 1980
- Sulphasalazine in rheumatoid arthritis.BMJ, 1980
- Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis.Proceedings of the National Academy of Sciences, 1975
- Controlled trial of sulphasalazine in the treatment of ulcerative colitisGut, 1964
- The Effect of Salicylazosulfapyridine (Azulfidine)® on Pustular Acne Vulgaris and Certain other DermatosesJournal of Investigative Dermatology, 1955